Editor’s Note: This article originally appeared on iMedX’s website.
iMedX, Inc. (iMedX), an international leader in revenue cycle management, medical documentation, and health information solutions has successfully completed the acquisition of Prevalent, Inc. (Prevalent) and Axcension, Inc. (Axcension). Both Axcension and Prevalent are proven providers of cutting-edge healthcare analytics and revenue cycle management consulting services.
The acquisition of these organizations completes another phase of iMedX’s ongoing global strategy to enhance healthcare technology and enable unparcelled insight into operations for healthcare facilities with the ultimate goal of improving patient care while also reducing costs.
Proprietary analytics technology from Prevalent, Axcension, and iMedX has been combined to create a never before seen business intelligence solution for healthcare providers, which allows for complete transparency and understanding across multiple systems.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
